Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · December 30, 2023

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin Induction for Untreated Brain Metastases From Breast Cancer

JAMA Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial
JAMA Oncol 2023 Dec 21;[EPub Ahead of Print], TW Chen, MS Dai, LM Tseng, SC Chen, TY Chao, TC Chao, YC Chang, CF Chiu, CT Liu, CH Lin, CY Liu, YF Chen, DY Chang, JC Yu, KM Rau, YY Hsieh, SC Shen, SM Huang, AL Cheng, YS Lu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading